SOX18 is a profound oncogene in many cancers, and FGF19/FGFR4 was found to upregulate SOX18 potentially through an interplay with Wnt signaling, specifically through the p-FRS2/p-GSK3β/β-catenin axis [101,103]. The gene discussed is SOX18; the disease is cancer.